Martingale Asset Management’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-46,904
| Closed | -$516K | – | 799 |
|
|
2023
Q1 | $516K | Buy |
46,904
+3,700
| +9% | +$40.7K | 0.01% | 608 |
|
|
2022
Q4 | $639K | Buy |
43,204
+16,096
| +59% | +$238K | 0.01% | 576 |
|
|
2022
Q3 | $519K | Buy |
+27,108
| New | +$519K | 0.01% | 613 |
|
|
2022
Q1 | – | Sell |
-23,111
| Closed | -$481K | – | 803 |
|
|
2021
Q4 | $481K | Buy |
23,111
+11,308
| +96% | +$235K | 0.01% | 652 |
|
|
2021
Q3 | $282K | Buy |
+11,803
| New | +$282K | ﹤0.01% | 764 |
|
|
2021
Q2 | – | Sell |
-7,208
| Closed | -$209K | – | 828 |
|
|
2021
Q1 | $209K | Buy |
+7,208
| New | +$209K | ﹤0.01% | 813 |
|